Factors Influencing the Timeliness and Completeness of Appropriate Staging Investigations for Patients with Stage I-III Lung Cancer in Southeastern Ontario.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
11 Oct 2024
Historique:
received: 15 08 2024
revised: 15 09 2024
accepted: 17 09 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

(1) Background: Comprehensive and timely lung cancer (LC) staging is essential for prognosis and management. The Lung Diagnostic Assessment Program (LDAP) in Southeastern (SE) Ontario aims to provide rapid, guideline-concordant care for suspected LC patients. We evaluated factors affecting the completeness and timeliness of staging for stage I-III LC patients in SE Ontario, including the impact of LDAP management. (2) Methods: This was a population-based retrospective cohort study using the LDAP database (January 2017-December 2019), linked with the Ontario Cancer Registry, to identify newly diagnosed LC patients. A Cox model approach identified variables associated with staging completeness and timeliness. (3) Results: Among 755 patients, 459 (60.8%) were managed through LDAP. Optimal staging was achieved in 596 patients (78.9%), 23 (3.0%) had alternative staging, and 136 (18.0%) had incomplete staging. In the adjusted analyses, LDAP management was associated with a higher likelihood of complete staging (OR 2.29,

Identifiants

pubmed: 39451757
pii: curroncol31100453
doi: 10.3390/curroncol31100453
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6073-6084

Subventions

Organisme : Ontario Lung Association
ID : Young Investigator Award
Organisme : Division of Respirology UHKF Research Award
ID : N.A.
Organisme : Translational Institute of Medicine at Queen's University
ID : N.A.

Auteurs

Shahad AlGhamdi (S)

Department of Medicine, Division of Respirology, Queen's University, Kingston, ON K7L 2V7, Canada.

Nilah Ahimsadasan (N)

School of Medicine, Queen's University, Kingston, ON K7L 2V7, Canada.

Weidong Kong (W)

Cancer Care and Epidemiology Research Unit, Queen's University, Kingston, ON K7L 2V7, Canada.

Michael Brundage (M)

Department of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.

Elizabeth A Eisenhauer (EA)

Department of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.

Christopher M Parker (CM)

Department of Medicine, Division of Respirology, Queen's University, Kingston, ON K7L 2V7, Canada.
Department of Critical Care Medicine, Queen's University, Kingston, ON K7L 2V7, Canada.

Andrew Robinson (A)

Department of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.

Andrew Giles (A)

Department of Surgery, Division of Thoracic surgery, Queen's University, Kingston, ON K7L 2V7, Canada.

Geneviève C Digby (GC)

Department of Medicine, Division of Respirology, Queen's University, Kingston, ON K7L 2V7, Canada.
Department of Oncology, Queen's University, Kingston, ON K7L 2V7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH